Pfizer’s Allergan Acquisition Paves The Way For A Split – But Delayed

Pfizer’s $160bn deal to buy Allergan and redomicile in Ireland could position the company better for an eventual split. But Pfizer said it will now wait until 2018 to decide if it will break up the company, disappointing some investors.